This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arbustini, E. Articles by Tavazzi, L. Search for Related Content PubMed PubMed Citation Articles by Arbustini, E. Articles by Tavazzi, L.

Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease

Eloisa Arbustini, MD^*,*, Andrea Pilotto, TD^*, Alessandra Repetto, MD, Maurizia Grasso, PhD^*, Andrea Negri, TD^*, Marta Diegoli, PhD^*, Carlo Campana, MD, Laura Scelsi, MD, Elisa Baldini, MD, Antonello Gavazzi, MD and Luigi Tavazzi, MD

^* Molecular Diagnostic Division, IRCCS Policlinico San Matteo, Pavia, Italy
Cardiology Division, IRCCS Policlinico San Matteo, Pavia, Italy
Cardiology Division, Ospedali Riuniti, Bergamo, Italy

View larger version (41K): [in a new window]   Figure 1 Localization of published lamin A/C (LMNA) mutations and corresponding phenotypes; the gray square contains the mutations found in this study. A-V = atrioventricular; DCM = dilated cardiomyopathy; EDMD = Emery-Dreifuss muscular dystrophy; FPL = familial partial lipodystrophy; LGMD = limb girdle muscular dystrophy.

View larger version (37K): [in a new window]   Figure 2 1) Family A: mutation E111X; 2) Family B: mutation K97E; 3) Family C: CTGC insertion at 2,869 of the cDNA; 4) Family D: mutation R190W; 5) Family E: mutation E317K. Filled symbols = patients; open symbols = non-affected subjects; question marks within symbols = non-proven affected subjects. Small squares within symbols = atrioventricular block (upper left), left ventricular dilation (upper right). Diagonal lines = death. The probands are indicated by arrows. The presence (+) or absence (–) of the mutation is indicated for the genetically tested family members. Chromatograms below each pedigree demonstrate the heterozygous mutations.

View larger version (173K): [in a new window]   Figure 3 Electron micrographs showing nuclear membrane damage (arrow) (a), bleb formation (arrow) (b) and c) and nuclear pore clustering (arrow) (d) in cardiac myocytes from myocardial samples of patients A-II-1 (a), B-III-1 (b), C-II-2 (c) and D-II-1 (d) (uranyl-acetate, lead citrate). Bar scales = 0.6 mµ.

View larger version (212K): [in a new window]   Figure 4 Lamin A/C immunostain (a, c, e) and corresponding DAPI nuclear stain (b, d, f). (a, b) Normal heart sample. (c, d) Control dilated cardiomyopathy without (LMNA) mutation; all myocyte and interstitial-vascular nuclei are immunostained by the anti-LMNA antibody. (e, f) Endomyocardial biopsy from patient A-II-1; note the absence of LMNA immunostain in some myocyte nuclei and positive interstitial-vascular cell nuclei (Avidin-Biotin Complex, DAPI nuclear stain; a and b, 40x; c to f, 110x).

View larger version (99K): [in a new window]   Figure 5 Atrioventricular junction of patients A-II-1 and B-III-1: fibrosclerosis and fibrofatty degeneration (Movat Pentachrome stain, 10x).

View larger version (68K): [in a new window]   Figure 6 Western blot showing lamin A and lamin C bands and the additional 30 kDa immunoreacting band corresponding to an abnormal small peptide comprising the epitope recognized by the antibody. This band is identical in patients with different lamin A/C (LMNA) mutations (lane 2: A-II-1; lane 3: B-III-1; lane 5: A-II-2) but absent in normal controls (lane 1) and patients with dilated cardiomyopathy unrelated to LMNA defects (lane 4).